期刊文献+

2,5-二乙酰氧甲基-3,6-二甲基吡嗪合成工艺改进 被引量:1

Synthesis and process improvement of 2,5-diacetoxymethyl-3,6-dimethylpyrazine
在线阅读 下载PDF
导出
摘要 目的优化2,5-二乙酰氧甲基-3,6-二甲基吡嗪的合成工艺。方法以川芎嗪为原料,在冰乙酸条件下经过30%H2O2氧化后,采用液态加料法与醋酐酯化反应得到目标产物;以高效液相色谱法,进行目标产物与对照品吸收峰峰面积的对比来计算产率,并考察反应温度和时间对酯化反应产率的影响。结果改进了合成工艺,简化了操作,总产率提高到69.12%。结论改进后的工艺切实可行,可操作性好,更适合工业化生产。 Objective To synthesize 2,5-diacetoxymethyl-3,6-dimethylpyrazine and to optimize technical conditions.Methods Tetramethylpyrazine and 30% hydrogen peroxide were reacted in glacial acetic acid to yield N,N-dioxotetramethylpyrazine,then heated and esterified to get target product.The yield was monitored by comparing peak area of target product with reference substance in HPLC.The reaction temperature and time were investigated by the method of liquid feeding.Results The synthetic process was improved,the operation was simplified and the overall yield was increased to 69.12%.Conclusion The improved synthetic process is practicable and suitable for large-scale manufacture
作者 房敏 李伟
机构地区 南京中医药大学
出处 《中国医药导报》 CAS 2012年第7期109-109,114,共2页 China Medical Herald
基金 国家自然科学基金资助项目(项目编号:81072542) 江苏省自然科学基金资助项目(项目编号:BK2011077)
关键词 2 5-二乙酰氧甲基-3 6-二甲基吡嗪 液态加料法 合成 工艺改进 2, 5-diacetoxymethyl-3, 6-dimethylpyrazine Liquid feeding Synthesis Process improvement
  • 相关文献

参考文献5

二级参考文献26

  • 1田振军,李红艳,张志琪,马新庭,郭进.川芎嗪对大鼠心肌细胞膜钙通道的影响及其作用机制[J].体育科学,2006,26(11):80-83. 被引量:8
  • 2YAN C, MILLER CL, ABE J. Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart [J]. Circ Res, 2007, 100(4) : 489-501.
  • 3PEDERSEN SF, O'DONNELL ME, ANDERSON SE, et al. Physiology and pathophysiology of Na^+/H^+ exchange and Na^+-K^+- 2Cl^- cotransport in the heart, brain, and blood[J]. Am J Physiol Regul Integr Comp Physiol, 2006, 291 ( 1 ) : R1-R25.
  • 4QIN J, VALLE G, NANI A, et al. Luminal Ca^2+ regulation of single cardiac ryanodine receptors: insights provided by calsequestrin and its mutants[J]. J Gen Physiol, 2008, 131 (4): 325- 334.
  • 5STAWSKY MT, COLUCCI WS, GOTTIEB SS. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators[J]. Circulation, 2000, 102(18) : 2222-2227.
  • 6COHN JN, ZIESCHE S, SMITH R, et al. Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFr Ⅲ. Vasodilator-Heart Failure Trial(V-HeFT) Study Group [J]. Circulation, 1997, 96(3): 856-863.
  • 7CLELAND JG, DAUBERT JC, ERDMANN E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure[J]. N Engl J Med, 2005, 352(15) : 1539-1549.
  • 8刘峥.Liguzinediol先导物的发现及正性肌力活性研究[D/OL].南京:南京中医药大学,2009:15-16[2010-05-11].http ://edmd.cnki.com.en/Artiele/CDM-10315-2009252145. htm.
  • 9OECD. Acute oral toxicity: up-and-down procedure[J/OL]. OECD Guidelines, 2010, 1 (4): 1-27.[2010-07-01].http://www ingentaeomect, com/content/oecd/1607310x/2001/00000001 / 00000004/9742501 e.
  • 10EPA. OPPTS guideline 870. 1100 acute oral toxicity[J/OL]. I-Iealth Effects Test Guidelines, December 2002: 1-35. [2010-05- 11]. http ://www.epa.gov/oppfeadl/harmonizatioin.

共引文献32

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部